These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-005972-34 Retrograd intrarenal stenkirurgi. En metode til behandling af den ESWL-resistente nyresten not-yet-due
Not reported 2006-002464-26 EFFEKTEN AF VELCADE PÅ KNOGLEVÆVET VED MYELOMATOSE (KNOGLEMARVSKRÆFT). 2009-07-07 due-trials
Not reported 2006-005756-32 Pharmacological modulation of the intrarenal pressure during endourological procedures in the upper urinary tract 2008-04-20 due-trials
Not reported 2007-003777-13 Knoglebinding af bisfosfonat (Zometa) hos patienter med myelomatose eller brystkræft med knoglemetastaser 2012-01-04 due-trials
Ongoing 2007-003890-20 Postoperativ smertebehandling efter total hoftealloplastik Et randomiseret, dobbeltblindet og placebo-kontrolleret studie til vurdering af effekten af lokalanalgesi not-yet-due
Completed, but no date Terminated 2007-004791-39 Et prospektivt randomiseret fase II studie til evaluering af Gabapentin og Venlafaxin´s virkning mod hedestigninger hos kvinder opereret for brystkræft og i antihormonbehandling i form af aromata... bad-data
Ongoing 2007-007137-38 En åbent randomiseret fase II undersøgelse af effekten af darbepoietin alfa (Aranesp®) til behandling af anæmi hos patienter med hormonrefraktær prostatacancer, der behandles med Taxotere not-yet-due
Not reported 2008-000878-20 Bevacizumab og Carboplatin til patienter med platinresistent epithelial ovariecancer 2015-08-04 due-trials
Reported results 2008-002367-14 Kombineret biologisk behandling og kemoterapi til patienter med inoperabelt cholangiocarcinom 2016-03-31 due-trials
Not reported 2008-003962-24 visceral pain originating from the upper urinary tract - a randomised controlled trial on the effect of morphine and oxycodone in patients undergoing percutaneus nephrolithotomy (PCNL) 2012-06-26 due-trials
Not reported Terminated 2008-004923-48 En fase II undersøgelse af Irinotecan og Panitumumab som 3. linje behandling til patienter med metastaserende colorectal cancer uden KRAS mutationer. 2012-11-19 due-trials
Reported results 2008-007665-22 En fase II undersøgelse af Temsirolimus og Irinotecan til behandlingsresistente patienter med metastaserende colorectal cancer og KRAS mutationer 2011-02-03 due-trials
Listed as ongoing, but also has a completion date 2008-007799-13 Panitumumab (Vectibix) and Pegylated Liposomal Doxorubicin (Caelyx) to platinum-resistant epithelial ovarian cancer with KRAS wild-type. 2012-10-31 bad-data
Not reported Terminated 2009-010539-41 Norspan versus Oxycontin som postoperativ smertebehandling til ekstracapsulære femurfraktur. Et randomiseret, dobbelt-blindet og placebo-kontrolleret pilotstudium. 2013-05-01 due-trials
Reported results 2009-015068-32 ”Et fase II-forsøg med standardkemoterapi og panitumumab til pati-enter med metastaserende NSCL udvalgt på basis af mutationsstatus" Phase II trial with standard chemotherapi and panutimumab to patie... 2013-11-15 due-trials
Not reported Terminated 2010-018700-90 En fase II undersøgelse af pemetrexed og gemcitabin til behandlingsresistente patienter med KRAS muteret metastaserende colorectal cancer 2011-08-16 due-trials
Reported results 2010-020385-13 Randomized phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable cholangiocarcinoma without KRAS mutations 2016-03-31 due-trials
Completed, but no date Terminated 2010-021618-42 En fase II undersøgelse af oral vinorelbin i kombination med trastuzumab til 1. og 2. linie behandling af kvinder med metastaserende HER2 positiv brystkræft bad-data
Completed, but no date, and reported results 2010-024050-10 Vertebroplasty versus periost infiltration with lidocain as pain treatment in osteoporotic fractures in the thoracic and lumbar spine bad-data
Exempt, with results 2011-002099-18 Veliparib (ABT888) Monotherapy for Patients with BRCA germline mutation and Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer 2016-01-29 not-yet-due
Reported results 2011-002751-34 An Open-Label Phase II Study of the Safety and Efficacy of Doxorubicin and Cyclophosphamide in Combination with Bortezomib, Lenalidomide, and Dexamethasone for Treatment of Patients with Newly Diagn... 2017-09-28 due-trials
Not reported 2011-004182-33 Phase II Study of gemcitabin and capecitabine in Chemotherapy Refractory Metastatic Colorectal Cancer 2012-05-30 due-trials
Reported results 2011-006152-36 Postoperative treatment with parathyroidea hormone Forteo® in patients undergoing posterolateral spinal fusion surgery. A prospektive and a randomized double-blinded, placebo-controlled study Parat... 2018-06-13 due-trials
Not reported Terminated 2012-001224-35 Cabazitaxel in platinum refractory ovarian cancer. A phase II trial 2014-07-01 due-trials
Exempt, with results 2012-001661-32 Veliparib (ABT888) and Topotecan (Hycamtin®) for Patients with Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer with Negative or Unknown BRCA Status 2015-02-01 not-yet-due
Not reported Terminated 2012-001924-37 Relaxation of the ureter during ureterorenoscopy Relaksation af ureter under ureterorenoskopi 2014-06-13 due-trials
Not reported 2012-004354-28 Maintenance treatment in childhood constipation. A randomized placebo-controlled intervention study Vedligeholdelsesbehandling ved simpel obstipation. Et randomiseret placebo kontrolleret interven... 2015-09-24 due-trials
Other 2013-002363-26 Neoadjuvant chemotherapy versus standard treatment in patients with locally advanced colon cancer not-yet-due
Reported results Terminated 2013-004475-13 Pharmacological relaxation of the ureter when using access sheaths during ureterorenoscopy Farmakologisk relaksation af ureter under anvendelse af ureteral access sheath i forbindelse med ureterore... 2018-09-28 due-trials
Reported results 2013-004858-18 Tocotrienol as a nutritional supplement in patients with advanced ovarian cancer 2019-07-02 due-trials
Not reported 2014-005189-31 “Monoclonal antibodies for treatment of multiple myeloma. Present status and aspects of effector mechanisms with emphasis on the CD38 antibody daratumumab ”. 2015-10-01 due-trials
Reported results 2015-002296-18 Cabazitaxel in patients with Recurrent Ovarian Cancer after failure of standard therapy- A phase II trial 2018-12-05 due-trials
Ongoing 2015-002326-39 The influence of fat intake, estrogen, age, and gender on postprandial lipds and glucose Forskellige fedttyper, østrogen, alderen og kønnets indflydelse på postprandiel lipid- og glukosemetabolisme... not-yet-due
Reported results 2015-002742-32 Tocotrienol as a nutritional supplement in patients with advanced pulmonal cancer 2019-05-09 due-trials
Completed, report not yet due 2015-004850-17 A randomized investigation of side effects to FOLFOXIRI in combination with tocotrienol or placebo as first line treatment of metastatic colorectal cancer. 2024-03-27 not-yet-due
Reported results 2016-000080-16 Tocotrienol in combination with neoadjuvant chemotherapy for women with breast cancer 2019-01-21 due-trials
Completed, but no date, and reported results 2017-000456-26 Predictive value of in-vitro testing anti-cancer therapy sensitivity on tumorspheres from patients with metastatic colorectal cancer bad-data
Reported results 2018-003112-53 Predictive value of in-vitro testing anti-cancer therapy sensitivity on tumoroids from patients with metastatic pancreatic cancer 2023-02-22 due-trials
Completed, report not yet due Terminated 2019-000618-13 Bevacizumab and tocotrienol in recurrent ovarian cancer. A marker based phase II trial 2024-07-30 not-yet-due
Reported results Terminated 2019-002071-34 Allocation of patients with pre-treated solid tumors to anti-cancer therapy based on gene expression drug response prediction - a phase II basket trial 2020-04-02 due-trials
Other 2019-004207-13 Tocotrienol and Bevacizumab in metastatic colorectal cancer. A randomized phase II marker trial not-yet-due
Other 2020-001102-29 Venetoclax and Dexamethasone in translocation (11;14) positive relapsed and refractory multiple myeloma (VICTORIA) not-yet-due
Reported results Terminated 2020-004349-35 Melphalan flufenamide (melflufen) and Dexamethasone re-induction in Daratumumab-refractory Multiple Myeloma as an Adjunct to Continued Daratumumab (MERMAID) Melfalan flufenamid (melflufen) og dexam... 2021-11-06 due-trials
Completed, report not yet due 2020-006110-20 Repeat dose steroid to prevent pain relapse after Total Knee Arthroplasty in patients with high pain response - A randomized blinded placebo-controlled trial Højdosis Steroid før og efter total knæ... 2024-04-19 not-yet-due
Completed, report not yet due 2021-002629-95 Cefuroxime and Piperacillin Concentrations in the Biliary System 2024-05-16 not-yet-due
Other 2022-004238-20 BONG: Breathlessness and alternatives to Opioid treatment in Non-malign Groups of severe lung disease Lindring af svær åndenød med Dronabinol hos patienter med svær Kronisk Obstruktiv Lungesygdom (... not-yet-due